Department of Translational Skin Cancer Research (TSCR), German Cancer Consortium (DKTK), Partner Site Essen, University Medicine Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of Dermatology, University Hospital Essen, Essen, Germany.
J Cancer Res Clin Oncol. 2023 Sep;149(11):8267-8277. doi: 10.1007/s00432-023-04733-y. Epub 2023 Apr 18.
Class I selective histone deacetylase inhibitors (HDACi) have been previously demonstrated to not only increase major histocompatibility complex class I surface expression in Merkel cell carcinoma (MCC) cells by restoring the antigen processing and presentation machinery, but also exert anti-tumoral effect by inducing apoptosis. Both phenomena could be due to induction of type I interferons (IFN), as has been described for HDACi. However, the mechanism of IFN induction under HDACi is not fully understood because the expression of IFNs is regulated by both activating and inhibitory signaling pathways. Our own preliminary observations suggest that this may be caused by suppression of HES1.
The effect of the class I selective HDACi domatinostat and IFNα on cell viability and the apoptosis of MCPyV-positive (WaGa, MKL-1) and -negative (UM-MCC 34) MCC cell lines, as well as, primary fibroblasts were assessed by colorimetric methods or measuring mitochondrial membrane potential and intracellular caspase-3/7, respectively. Next, the impact of domatinostat on IFNA and HES1 mRNA expression was measured by RT-qPCR; intracellular IFNα production was detected by flow cytometry. To confirm that the expression of IFNα induced by HDACi was due to the suppression of HES1, it was silenced by RNA interference and then mRNA expression of IFNA and IFN-stimulated genes was assessed.
Our studies show that the previously reported reduction in viability of MCC cell lines after inhibition of HDAC by domatinostat is accompanied by an increase in IFNα expression, both of mRNA and at the protein level. We confirmed that treatment of MCC cells with external IFNα inhibited their proliferation and induced apoptosis. Re-analysis of existing single-cell RNA sequencing data indicated that induction of IFNα by domatinostat occurs through repression of HES1, a transcriptional inhibitor of IFNA; this was confirmed by RT-qPCR. Finally, siRNA-mediated silencing of HES1 in the MCC cell line WaGa not only increased mRNA expression of IFNA and IFN-stimulated genes but also decreased cell viability.
Our results demonstrate that the direct anti-tumor effect of HDACi domatinostat on MCC cells is at least in part mediated via decreased HES1 expression allowing the induction of IFNα, which in turn causes apoptosis.
I 类选择性组蛋白去乙酰化酶抑制剂(HDACi)不仅通过恢复抗原加工和呈递机制增加默克尔细胞癌(MCC)细胞表面主要组织相容性复合体 I 的表达,而且通过诱导细胞凋亡发挥抗肿瘤作用。这两种现象都可能是由于诱导 I 型干扰素(IFN)引起的,正如 HDACi 所描述的那样。然而,由于 IFN 的表达受激活和抑制信号通路的调节,因此 HDACi 诱导 IFN 的机制尚未完全理解。我们自己的初步观察表明,这可能是由于 HES1 的抑制所致。
通过比色法或测量线粒体膜电位和细胞内 caspase-3/7 来评估 I 类选择性 HDACi 地美司坦和 IFNα 对 MCPyV 阳性(WaGa、MKL-1)和阴性(UM-MCC 34)MCC 细胞系以及原代成纤维细胞活力和细胞凋亡的影响。接下来,通过 RT-qPCR 测量地美司坦对 IFNA 和 HES1 mRNA 表达的影响;通过流式细胞术检测细胞内 IFNα 的产生。为了证实 HDACi 诱导的 IFNα 表达是由于 HES1 的抑制,通过 RNA 干扰使其沉默,然后评估 IFNA 和 IFN 刺激基因的 mRNA 表达。
我们的研究表明,先前报道的地美司坦抑制 HDAC 后 MCC 细胞系活力降低伴随着 IFNα 表达的增加,无论是在 mRNA 水平还是在蛋白质水平。我们证实,用外源性 IFNα 处理 MCC 细胞可抑制其增殖并诱导细胞凋亡。对现有单细胞 RNA 测序数据的重新分析表明,地美司坦诱导 IFNα 的发生是通过抑制 HES1 实现的,HES1 是 IFNA 的转录抑制剂;这通过 RT-qPCR 得到了证实。最后,WaGa MCC 细胞系中 HES1 的 siRNA 介导沉默不仅增加了 IFNA 和 IFN 刺激基因的 mRNA 表达,还降低了细胞活力。
我们的结果表明,HDACi 地美司坦对 MCC 细胞的直接抗肿瘤作用至少部分是通过降低 HES1 表达介导的,从而允许诱导 IFNα,进而导致细胞凋亡。